Each week we highlight five things you need to know in the life sciences industry. … READ MORE >
biotech
5 things to know in life sciences: Week of July 26
From the development of an insulin biosimilar to a new tool matching mental health providers with patients, each week we highlight five things you need to know in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of March 29
From biopharma merger scrutiny to AI-powered biology research, we highlight what’s happening in the life sciences industry this week. … READ MORE >
5 things to know in life sciences: Week of Feb. 15
In this week’s roundup we look at promising results in a clinical trial leveraging an existing diabetes drug to treat obesity, a new and less invasive treatment for sleep apnea, the impact of the pandemic on oncology trials and more. … READ MORE >
5 things to know in life sciences: Week of Feb. 8
Recent industry news includes the impact of new COVID-19 variants on existing vaccines for the disease, the outlook for drug pricing reforms under the Biden administration, and the promise of 3D-printed hearts. … READ MORE >
CHART OF THE DAY: How COVID-19 vaccines compare on cold storage requirements
Local facilities face logistical hurdles in maintaining the ultra-low storage temps needed for COVID-19 vaccines. This graphic shows how the vaccines from Pfizer, Moderna and Johnson & Johnson compare in terms of their storage requirements. … READ MORE >
5 things to know this week in life sciences: Week of Jan. 11
News this week included Bluebird Bio’s announcement about splitting into two companies, the promise of quantum computing in drug design, and how mRNA platforms offer promise for diseases beyond COVID-19. … READ MORE >
5 things to know this week in life sciences: Week of Jan. 4
In this week’s industry roundup, we look at recent drug price increases, the ongoing battle over 340B program discounts, key catalysts in Q1 for middle market biotech companies, and more. … READ MORE >
5 things to know this week in life sciences: Week of Dec. 21
With approval of Moderna’s COVID-19 vaccine last week for emergency use, many of us are looking forward to getting vaccinated. But this is also a good time to reflect on the decades of work that laid the groundwork for this lightning fast vaccine development effort. … READ MORE >
Biotech needs cash in hesitant market
Life science companies require a cash infusion at least twice as big as that of 2018 to fund research and development at a time when investors remain skittish, according to a Bloomberg analysis. … READ MORE >